Xenon’s epilepsy drug clears phase 1b, setting stage for trial in patients…
A phase 1b trial has linked Xenon’s epilepsy candidate XEN1101 to statistically significant declines in measures of corticospinal and cortical excitability.…
Browsing Tag
drug
Esperion’s cholesterol drug cuts LDL-C in phase 3 | Digital Science
A phase 3 trial has found that adding Esperion’s bempedoic acid to Zetia lowers LDL cholesterol by more than the statin alone. The result sets Esperion to file…
Zai Lab cans ex-GlaxoSmithKline eczema drug after phase 2 flop | Digital…
Zai Lab has stopped development of a treatment for atopic dermatitis after it failed to beat placebo in a phase 2a trial. The Shanghai-based biotech licensed…
Top dark web drug vendors nabbed by ‘Operation Darkness Falls’ | Cyber…
Latest breaking news on Cyber securityThe US government stepped up its attack on dark web criminals this week, announcing the arrests of several alleged drug…
Unraveling the mysteries of drug resistance in melanoma with CRISPR-Cas9 |…
About half of melanoma patients have mutations in BRAF genes, which can be addressed with drugs like Roche’s Zelboraf. But many patients eventually grow…
PBS NewsHour: Why a Patient Paid a $285 Copay for a $40 Drug | Digital…
A featured story by PBS NewsHour reaffirms that insurance companies and drug cost middlemen determine what patients pay out of pocket for prescription drugs,…
Approval of first RNA interference drug – why the excitement? | Digital…
By nobeastsofierce / shutterstock.com”>
Single strands of ribonucleic acid (RNA) are now being used to treat disease. Credit: By nobeastsofierce /…
Pfizer contracts with Antares to build a rescue auto-injector for an…
Pfizer has tapped Antares Pharma for the development of a self-administered combination drug-device rescue pen for an undisclosed medicine, shortly after…
Certara modeling aided 95% drug approvals in the first half of 2018, as the…
Certara reported that its drug development software, including modeling and simulation services, supported 95% of the 20 novel drugs approved by the FDA in the…
Celtaxsys’ cystic fibrosis drug reduces lung exacerbations in phase 2 study…
Celtaxsys’ oral anti-inflammatory drug for cystic fibrosis, acebilustat, cleared a phase 2 study by demonstrating meaningful improvements in pulmonary…